Third Australian report on antimicrobial use and resistance in human health
10 May 2019
The Antimicrobial Use and Resistance in Australia (AURA) Surveillance system provides data and information to support Australia’s strategic response to one of the most significant challenges facing health care
around the world: antimicrobial resistance (AMR).
AMR reduces the range of antimicrobials available to treat infections, and increases morbidity and mortality associated with infections caused by multidrug-resistant organisms. AMR is well established as a priority for action due to its serious and growing impact on human health.
Further reading: AURA 2019 (full report)
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!